1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEUROCRINE BIOSCIENCES, INC.
Neurocrine Biosciences, Inc. XNAS: NBIX
142.73 1.83 (1.30%)
610.9K
XNAS Volume

XNAS 17 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Board Meeting
The board meeting for Neurocrine Biosciences, Inc. is scheduled for today, for the purpose of TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry and Epilepsy Virtual Summit See details

US Politician trade disclosures for Neurocrine Biosciences, Inc. from August 13, 2025 to September 17, 2025

Representative Lisa McClain discloses a trade of $1K-15K in Neurocrine Biosciences, Inc., made on August 13, 2025.

Members of Congress or their families often buy or sell securities and have access to non-public information through their roles. The STOCK Act requires them to report these trades within 45 days to ensure transparency and reduce conflicts of interest.